• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB1200002 注射用重组变构人肿瘤坏死因子相关凋亡诱导配体 Aponermin Lyophilized Biological Products Supplementary Application 2012-04-24 北京沙东生物技术有限公司 Beijing Shadong Biotech Co Ltd Certificate Issued 2012-12-25 view
CXSB1200001 注射用重组变构人肿瘤坏死因子相关凋亡诱导配体 Aponermin Lyophilized Biological Products Supplementary Application 2012-04-24 北京沙东生物技术有限公司 Beijing Shadong Biotech Co Ltd Certificate Issued 2012-12-25 view
CXSB1200003 注射用重组变构人肿瘤坏死因子相关凋亡诱导配体 Aponermin Lyophilized Biological Products Supplementary Application 2012-04-24 北京沙东生物技术有限公司 Beijing Shadong Biotech Co Ltd Certificate Issued 2012-12-25 view
CXSB1200004 注射用重组变构人肿瘤坏死因子相关凋亡诱导配体 Aponermin Lyophilized Biological Products Supplementary Application 2012-04-24 北京沙东生物技术有限公司 Beijing Shadong Biotech Co Ltd Certificate Issued 2012-12-25 view
CXSS2101065 注射用重组变构人肿瘤坏死因子相关凋亡诱导配体 Aponermin Lyophilized Biological Products(1) New Drug Application 2021-12-20 Wuhan Hiteck Biological Pharma Co Ltd view